AzTrials
AzTrials

Respiratory MorbidityCOMICUSROMNCT06537362

Mouthpiece With Integrated Cheek Support vs. Manual Cheek Support During Respiratory Oscillometry

A study testing Mouthpiece with cheek-holder in people with Respiratory Morbidity and Lung Function Decreased, run by Politecnico di Milano at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study aims to evaluate the measurement accuracy of respiratory impedance during oscillometry (or Forced Oscillation Technique - FOT) under the following conditions: 1)The subject's cheeks are manually supported by an expert (Gold Standard method), 2) The subject's cheeks are supported by an integrated cheek… Read more about this study

Who is it for?
Ages 5 to 75 yearsHealthy volunteers can take part
What is being tested?
Mouthpiece with cheek-holder
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
55 participants
Where
1 siteItaly
Study dates
26 Mar 2024to Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • subjects aged between 5 and 75 years

Who cannot join

  • Subjects unable to follow the study procedures or with any physical or mental condition deemed unsuitable by the doctor will be excluded from the study

Trial locations and contacts

1 site in 1 country.

Raffale Dellaca, PhD contact

0223999005

raffaele.dellaca@polimi.it

Chiara Veneroni, PhD contact

0223999024

chiara.veneroni@polimi.it

Italy1 site, 1 recruiting
  • Allergy and Pneumology Outpatient Clinic

    Bergamo

    Marcello Cottini, cottinimarcello@gmail.com

    Recruiting

Other trials in Italy

About this study

Official title: Comparative Evaluation of the Use of a Mouthpiece With Integrated Cheek Support vs. Manual Cheek Support During Respiratory Oscillometry Measurements

The study aims to evaluate the measurement accuracy of respiratory impedance during oscillometry (or Forced Oscillation Technique - FOT) under the following conditions: 1)The subject's cheeks are manually supported by an expert (Gold Standard method), 2) The subject's cheeks are supported by an integrated cheek support in the mouthpiece.

It is a prospective, randomized, cross-over study on Subjects who will present themselves at the offices of the participating doctors, aged between 5 and 75 years. The primary outcome is to Compare the respiratory impedance measurements under the two measurement conditions. Secondary Objectives are to: i)evaluate the patient's comfort during the measurement with the cheek support and compare this comfort to the gold standard condition; ii) assess the maximum and minimum face dimensions of the recruited subjects that allow for effective and comfortable cheek support; iii) evaluate the type and frequency of measurement errors introduced by the use of the integrated cheek support in the mouthpiece.

Read the detailed description

Study design: prospective, randomized, cross-over study. Study population: Subjects who will present themselves at the participating doctors' offices. Inclusion criteria: subjects aged between 5 and 75 years. Exclusion criteria: Subjects unable to follow the study procedures or with any physical or mental condition deemed unsuitable by the doctor will be excluded from the study.

Study protocol: the measurement protocol will consist of measuring the subject's facial morphological parameters and respiratory impedance parameters, followed by the administration of a questionnaire on perceived comfort. The procedure will be performed in a seated position.

Measurements:

  1. Morphological Parameters Using a sliding caliper. The following anatomical distances will be measured on the seated subject, looking straight ahead with teeth together, facial muscles relaxed, and mouth closed: a) BIGONIAL WIDTH: The straight-line distance between the right and left angles of the mandible; b) LIP LENGTH: The straight-line distance between the right and left corners of the closed mouth."
  2. Respiratory Impedance. The impedance measurement will be performed using the Resmon FIRST (Restech srl, Milan, Italy). Repeated measurements will be taken for each subject three times (TRIPLICATE) over 10 breaths with mono-frequency oscillations at 5 Hz. The enrolled subjects will perform the following measurements in a random order:
  • One TRIPLICATE session of respiratory impedance with cheeks supported by study personnel.
  • One TRIPLICATE session of respiratory impedance with cheeks supported by the cheek support. The study personnel will record any operator errors associated with preparing and using the cheek support on the enrolled participants.
  1. Comfort Evaluation Questionnaire. At the end of the measurements, each participant will be asked to complete a comfort evaluation questionnaire regarding their experience during the procedure. Currently, no commercial devices are similar to the cheek support being tested. Therefore, the questionnaire is a modified version of a questionnaire previously used to evaluate the comfort of mechanical respirators worn on patients' faces during the coronavirus disease (COVID-19) period (Respirator Comfort, Wearing Experience, and Function Instrument (R-COMFI)3). The questionnaire aims to cover sensations of discomfort and general impressions of using the mouthpiece with cheek support during respiratory oscillometry measurements.

Sample size: The total number of subjects to be enrolled in the study is 55. This number was determined based on the following assumptions:

  • Type-I error (α) = 5%, study power (1-β) >= 80%
  • Uniform distribution of subjects in the following age groups: 6-17, 18-75 years
  • Range of Resistance (Rrs) = 2...15 cmH2O/(L/s)
  • Range of Reactance (Xrs) = 0...-14 cmH2O/(L/s)
  • Minimum expected differences: the investigators set the minimum expected difference at 10% with a minimum value of 0.1 cmH2O/(L/s) (see table below)
  • Expected standard deviation of variation: the investigators assume the expected standard deviation of variation to be the standard deviation of the short-term repeatability of oscillometry measurements reported in the literature (see table below)
  • Dropout rate = 10%

Data analysis:

  1. Comparison between the Cheek Holder Mouthpiece and Operator Support. The differences between the measurements taken with manual cheek support and those taken with the cheek holder will be analyzed. The two methods will be considered equivalent if the mean difference between the results and the 95% confidence interval of the Deming regression fall within the expected short-term variability of the technique for the tested population. Specifically:
  • For Rrs, a difference within 17% in adults and 27% in children, with a minimum acceptable difference of 1 cmH2O/(L/s), will be considered acceptable.
  • For Xrs, a difference within 37% in adults and 40% in children, with a minimum acceptable difference of 0.5 cmH2O/(L/s), will be considered acceptable.
  1. Evaluation of Patient Comfort. The comfort of each patient will be assessed using a scoring system associated with specific questions. The total scores obtained with the two methodologies will be compared using a paired t-test or alternative tests for non-parametric distributions.
  2. Evaluation of the Impact of Face Dimensions on FOT Test Accuracy. The impact of face dimensions on the effectiveness of the cheek holder support will be assessed by investigating the presence of a correlation between the differences in results obtained with the cheek holder and those obtained with manual support by the physician relative to lip length (LIP) and bigonial width. The type and frequency of user errors will be summarized for the entire population and for each age group using descriptive statistics (mean and standard deviation or median and ranges, as appropriate).
Being tested
Mouthpiece with cheek-holder
Keywords
Oscillometry
Medical subject headings
Respiratory Insufficiency

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mouthpiece with cheek-holderDevice

    A cheek support integrated into the mouthpiece is used for the measures

Study groups in NCT06537362
Study groupRoleWhat they receive
ControlNo interventionDuring oscillometry measures, the subject's cheeks are manually supported by an expert (Gold Standard method)
Cheek HolderExperimentalDuring oscillometry measures, the subject's cheeks are supported by an integrated cheek support in the mouthpiece
Receives: Device: Mouthpiece with cheek-holder

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. impedance measurements

    Compare the respiratory respiratory resistance (cmH2O*s/L) and reactance (cmH2O*s/L) at 5 Hz under the two measurement conditions

    Measured: within session (about 15 min)

Secondary outcomes (3)
  1. evaluate patient's comfort during the measurement with the cheek support

    evaluate the patient's comfort during the measurement with the cheek support and compare this comfort to the gold standard condition as quantified by the questionnaire

    Measured: within session (about 15 min)

  2. face dimensions allowing for effective and comfortable cheek support

    assess the maximum and minimum face dimensions (to lip length and bigonial width) of the recruited subjects that allow for effective and comfortable cheek support as detailed in the Data Analysis section

    Measured: within session (about 15 min)

  3. evaluate the type and frequency of measurement errors

    evaluate the type and frequency of measurement errors introduced by the use of the integrated cheek support in the mouthpiece.

    Measured: within session (about 15 min)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2024
  2. Study start26 Mar 2024
  3. Primary completionAug 2024 (estimated)
  4. Study completionAug 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
55 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06537362
Sponsor's protocol ID
CheekHolder
Acronym
COMICUSROM
Status last verified
Aug 2024
First submitted
8 Jul 2024
Last updated
28 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Mouthpiece with cheek-holder in people with Respiratory Morbidity and Lung Function Decreased, run by Politecnico di Milano at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Raffale Dellaca, PhD (0223999005, raffaele.dellaca@polimi.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

impedance measurements (time frame: within session (about 15 min)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in